Article Text
Summary
Hydroxychloroquine (HCQ) is a commonly used drug for the treatment of systemic lupus erythematosus (SLE). Renal involvement is common in SLE. We present a 25-year-old woman with lupus nephritis on peritoneal dialysis whose lupus was quite silent for almost three years, and secondary to HCQ she developed severe hypoglycaemic episodes, which were completely resolved after stopping HCQ.
- renal system
- unwanted effects/adverse reactions
- dialysis
- systemic lupus erythematosus
- drugs: musculoskeletal and joint diseases
Statistics from Altmetric.com
Footnotes
Contributors AE-S has reviewed the literature and written the first draft. KA-O and AKA-H have participated in the discussion section and revised the draft for the final version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
